W. Carlton Reckling, MD* discusses his personal iFuse Case Series
*Dr. Reckling is the Vice President of Medical Affairs at SI-BONE, Inc.
The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: si-bone.com/risks
We can help. Tell us what you're looking for below.